Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2014 | 1 |
2017 | 1 |
2018 | 1 |
2019 | 1 |
2023 | 1 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Utility values in health technology assessments: a statistician's perspective.
Pharm Stat. 2014 May-Jun;13(3):184-95. doi: 10.1002/pst.1616. Epub 2014 Apr 2.
Pharm Stat. 2014.
PMID: 24692364
Different Weights of the Evidence-Based Medicine Triad in Regulatory, Health Technology Assessment, and Clinical Decision Making.
Schlegl E, Ducournau P, Ruof J.
Schlegl E, et al. Among authors: ducournau p.
Pharmaceut Med. 2017;31(4):213-216. doi: 10.1007/s40290-017-0197-3. Epub 2017 Jul 11.
Pharmaceut Med. 2017.
PMID: 28824273
Free PMC article.
Item in Clipboard
The role of stakeholder involvement in the evolving EU HTA process: Insights generated through the European Access Academy's multi-stakeholder pre-convention questionnaire.
Van Haesendonck L, Ruof J, Desmet T, Van Dyck W, Simoens S, Huys I, Giuliani R, Toumi M, Dierks C, Dierks J, Cardone A, Houÿez F, Pavlovic M, Berntgen M, Mol PGM, Schiel A, Goettsch W, Gianfrate F, Capri S, Ryan J, Ducournau P, Solà-Morales O, Julian E.
Van Haesendonck L, et al. Among authors: ducournau p.
J Mark Access Health Policy. 2023 Jun 4;11(1):2217543. doi: 10.1080/20016689.2023.2217543. eCollection 2023.
J Mark Access Health Policy. 2023.
PMID: 37284060
Free PMC article.
Item in Clipboard
Leveraging EUnetHTA's conceptual framework to compare HTA decision drivers in France, Italy, and Germany from a manufacturer's point of view.
Giuliani G, Chassagnol F, Traub D, Gyldmark M, Hebborn A, Ducournau P, Ruof J.
Giuliani G, et al. Among authors: ducournau p.
Health Econ Rev. 2018 Sep 21;8(1):24. doi: 10.1186/s13561-018-0201-y.
Health Econ Rev. 2018.
PMID: 30242522
Free PMC article.
Item in Clipboard
An Inclusive Civil Society Dialogue for Successful Implementation of the EU HTA Regulation: Call to Action to Ensure Appropriate Involvement of Stakeholders and Collaborators.
Desmet T, Julian E, Van Dyck W, Huys I, Simoens S, Giuliani R, Toumi M, Dierks C, Dierks J, Cardone A, Houÿez F, Pavlovic M, Berntgen M, Mol P, Schiel A, Goettsch W, Gianfrate F, Capri S, Ryan J, Ducournau P, Solà-Morales O, Ruof J.
Desmet T, et al. Among authors: ducournau p.
J Mark Access Health Policy. 2024 Mar 14;12(1):21-34. doi: 10.3390/jmahp12010004. eCollection 2024 Mar.
J Mark Access Health Policy. 2024.
PMID: 38544972
Free PMC article.
Item in Clipboard
Timely, consistent, transparent assessment of market access evidence: implementing tools based on the HTA Core Model® in a pharmaceutical company.
Ducournau P, Irl C, Tatt I, McCarvil M, Gyldmark M.
Ducournau P, et al.
Int J Technol Assess Health Care. 2019 Jan;35(1):10-16. doi: 10.1017/S0266462318003653. Epub 2019 Feb 21.
Int J Technol Assess Health Care. 2019.
PMID: 30789111
Free PMC article.
Item in Clipboard
Cite
Cite